恢复AAV2载体对人肝脏的天然嗜性
研究从人肝样本中获取天然嗜肝AAV衣壳序列,发现细胞培养传代导致的衣壳突变通过增加HSPG结合削弱了AAV2对人肝细胞的天然嗜性;在FRG人源化肝小鼠中重新适应可恢复嗜性,提示天然AAV衣壳可能更适合肝靶向基因治疗。
要点
- 培养适应的AAV2衣壳突变增加HSPG结合并降低人肝细胞嗜性
- 人肝来源天然AAV衣壳可能优于培养适应AAV2用于肝靶向
- HSPG高亲和力并非AAV2进入人肝细胞所必需
核心结论
- AAV2对HSPG的高亲和力并非其进入人肝细胞所必需,天然人肝来源AAV衣壳可能更适于肝靶向基因治疗。
研究设计与样本
- 从原代人肝样本中获取天然嗜肝AAV衣壳序列,并在Fah-/-/Rag2-/-/Il2rg-/-(FRG)人源化肝小鼠中评估AAV2的体内嗜性。
主要发现
- AAV2在FRG人源化肝小鼠中功能不佳,与其体外高效转导人肝细胞来源细胞系不一致。
- 衣壳突变(可能为组织培养传代的无意结果)减弱了天然AAV2及相关人肝AAV分离株对人肝的固有嗜性。
- 这些突变导致氨基酸改变,增加了与HSPG的结合,而HSPG曾被视为介导AAV2感染人肝细胞的主要细胞受体。
- 天然AAV变体体外传代出现组织培养适应并丧失对人肝细胞的嗜性。
- 原型AAV2在FRG人源化肝小鼠体内重新适应后,通过降低HSPG结合恢复了其固有肝嗜性。
临床怎么用
- 肝靶向基因治疗选用AAV载体时,应关注衣壳是否因体外培养传代而丧失天然肝嗜性。
- 避免仅以HSPG亲和力作为筛选人肝细胞靶向AAV2载体的指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent clinical successes in gene therapy applications have intensified interest in using adeno-associated viruses (AAVs) as vectors for therapeutic gene delivery. Although prototypical AAV2 shows robust in vitro transduction of human hepatocyte-derived cell lines, it has not translated into an effective vector for liver-directed gene therapy in vivo. This is consistent with observations made in Fah-/-/Rag2-/-/Il2rg-/- (FRG) mice with humanized livers, showing that AAV2 functions poorly in this xenograft model. Here, we derived naturally hepatotropic AAV capsid sequences from primary human liver samples. We demonstrated that capsid mutations, likely acquired as an unintentional consequence of tissue culture propagation, attenuated the intrinsic human hepatic tropism of natural AAV2 and related human liver AAV isolates. These mutations resulted in amino acid changes that increased binding to heparan sulfate proteoglycan (HSPG), which has been regarded as the primary cellular receptor mediating AAV2 infection of human hepatocytes. Propagation of natural AAV variants in vitro showed tissue culture adaptation with resulting loss of tropism for human hepatocytes. In vivo readaptation of the prototypical AAV2 in FRG mice with a humanized liver resulted in restoration of the intrinsic hepatic tropism of AAV2 through decreased binding to HSPG. Our results challenge the notion that high affinity for HSPG is essential for AAV2 entry into human hepatocytes and suggest that natural AAV capsids of human liver origin are likely to be more effective for liver-targeted gene therapy applications than culture-adapted AAV2.
引用
- Cabanes-Creus M, Hallwirth CV, Westhaus A, et al. Restoring the natural tropism of AAV2 vectors for human liver. Sci Transl Med. 2020. PMID: 32908003. doi:10.1126/scitranslmed.aba3312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。